Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 1;9(9):CD009379.
doi: 10.1002/14651858.CD009379.pub3.

Amniotic membrane transplantation for acute ocular burns

Gerry Clare  1 , Catey Bunce  2 , Stephen Tuft  1
Affiliations
Review

Amniotic membrane transplantation for acute ocular burns

Gerry Clare et al. Cochrane Database Syst Rev. .

Abstract

Background: Ocular surface burns can be caused by chemicals (alkalis and acids) or direct heat. One effect of the burn is damage to the limbal epithelial stem cells of the ocular surface with delayed re-epithelialisation, stem cell failure, and conjunctivalisation of the cornea. Amniotic membrane transplantation (AMT) performed in the acute phase (day 0 to day 7) following an ocular surface burn is claimed to reduce pain and accelerate healing. The surgery involves securing a layer of amniotic membrane (AM) to the eyelid margins as a patch to cover the entire ocular surface. However, there is debate about the severity of an ocular burn that may benefit from AMT and uncertainty of whether AMT improves outcomes.

Objectives: To compare the effect of AMT with medical therapy in the first seven days after an ocular surface burn, compared to medical therapy alone.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL; which contains the Cochrane Eyes and Vision Trials Register; 2021, Issue 9); Ovid MEDLINE; Ovid Embase; LILACS; the ISRCTN registry; ClinicalTrials.gov and the WHO ICTRP. We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 29 September 2021.

Selection criteria: We included randomised trials that compared an AMT applied in the first seven days following an ocular surface burn in addition to medical therapy with medical therapy alone. The outcome measures were failure of re-epithelialisation by day 21 post injury, visual acuity at final follow-up, corneal neovascularisation, symblepharon, time to re-epithelialisation and adverse effects.

Data collection and analysis: Two review authors independently screened search results, assessed the included studies for risk of bias and extracted relevant data. We contacted trial investigators for missing information. We summarised data using risk ratios (RRs) and mean differences (MDs) as appropriate.

Main results: We analysed two RCTs, but excluded individual patients who had been treated outside the acute phase in one of the studies (data provided by study authors). In total, 36 moderate burns from one RCT and 92 severe burns from two RCTs were evaluated separately. For both categories, the certainty of the evidence was downgraded principally as a result of high risks of performance and detection biases, and because of imprecision indicated by very wide confidence intervals. In addition, follow-up was insufficiently frequent to calculate time-to-epithelialisation precisely. Moderate severity ocular burns (Roper-Hall classification II-III) The relative risk of AMT on failure of epithelialisation by day 21 was 0.18 (0.02 to 1.31), and LogMAR visual acuity was 0.32 lower (0.55 to 0.09 lower) in the treatment group (i.e. better), suggesting a possible benefit of AMT. The GRADE assessment for failure of epithelialisation by day 21 was downgraded to very low due to the risk of bias and imprecision (very wide confidence intervals including no effect). The GRADE assessment for visual acuity at final follow-up was downgraded to low due to the risk of bias and imprecision (optimal information size not met). The relative effects of AMT on corneal neovascularisation (RR 0.56; 0.21 to 1.48), symblepharon (RR 0.41; 0.02 to 9.48) and time-to-epithelialisation (13 days lower; 26.30 lower to 0.30 higher) suggest possible benefit of AMT, but the wide confidence intervals indicate that both harm and benefit are possible. GRADE assessments for these outcomes were once again downgraded to very low due to the risk of bias and imprecision. Since adverse effects are rare, the small sample would have fewer occurrences of rare but potentially important adverse effects. The GRADE assessment for adverse effects was therefore considered to be low. Severe ocular burns (Roper-Hall classification IV) The relative risk of AMT on failure of epithelialisation by day 21 was 1.03 (0.94 to 1.12), and LogMAR visual acuity was 0.01 higher (0.29 lower to 0.31 higher) in the treatment group (i.e, worse), indicating no benefit of AMT. GRADE assessments for failure of epithelialisation by day 21 and final outcomes were downgraded to low. The relative effects of AMT on corneal neovascularisation (RR 0.84; 0.66 to 1.06), symblepharon (RR 0.89; 0.56 to 1.42) and time-to-epithelialisation (1.66 days lower; 11.09 lower to 7.77 higher) may include both benefit and harm. GRADE assessments for corneal neovascularisation, symblepharon and time-to-epithelialisation were downgraded to low due to risk of bias and imprecision. For adverse effects, the GRADE assessment was downgraded to low, reflecting the small sample sizes in the RCTs.

Authors' conclusions: There is uncertain evidence to support the treatment of moderate acute ocular surface burns with AMT in addition to standard medical therapy as a means of preventing failure of epithelialisation by day 21, improving visual outcome and reducing corneal neovascularisation, symblepharon formation and time-to-epithelialisation. For severe burns, the available evidence does not indicate any significant benefit of treatment with AMT.

PubMed Disclaimer

Conflict of interest statement

GC: None known. CB: None known. ST: None known.

Figures

1
1
Flow diagram
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Survival curves of epithelial defects of moderate ocular burns treated during first 7 days with AMT (data obtained from authors of Tandon 2011).
4
4
Survival curves of epithelial defects of severe ocular burns treated during first 7 days with AMT (data obtained from authors of Tandon 2011).
1.1
1.1. Analysis
Comparison 1: AMT with medical therapy versus medical therapy alone ‐ moderate burns, Outcome 1: Failure of epithelialisation (21 days)
1.2
1.2. Analysis
Comparison 1: AMT with medical therapy versus medical therapy alone ‐ moderate burns, Outcome 2: Visual acuity at final follow‐up
1.3
1.3. Analysis
Comparison 1: AMT with medical therapy versus medical therapy alone ‐ moderate burns, Outcome 3: Corneal neovascularisation
1.4
1.4. Analysis
Comparison 1: AMT with medical therapy versus medical therapy alone ‐ moderate burns, Outcome 4: Symblepharon
1.5
1.5. Analysis
Comparison 1: AMT with medical therapy versus medical therapy alone ‐ moderate burns, Outcome 5: Time‐to‐epithelialisation
2.1
2.1. Analysis
Comparison 2: AMT with medical therapy versus medical therapy alone ‐ severe burns, Outcome 1: Failure of epithelialisation (21 days)
2.2
2.2. Analysis
Comparison 2: AMT with medical therapy versus medical therapy alone ‐ severe burns, Outcome 2: Visual acuity at final follow‐up
2.3
2.3. Analysis
Comparison 2: AMT with medical therapy versus medical therapy alone ‐ severe burns, Outcome 3: Corneal neovascularisation
2.4
2.4. Analysis
Comparison 2: AMT with medical therapy versus medical therapy alone ‐ severe burns, Outcome 4: Symblepharon
2.5
2.5. Analysis
Comparison 2: AMT with medical therapy versus medical therapy alone ‐ severe burns, Outcome 5: Time‐to‐epithelialisation
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Eslani 2019 {published data only (unpublished sought but not used)}
    1. Eslani M, Baradaran-Rafii A, Cheung AY, Kurji KH, Hasani H, Djalilian AR, et al. Amniotic membrane transplantation in acute severe ocular chemical injury: a randomized clinical trial. American Journal of Ophthalmology 2019;199:209-15. - PubMed
Tandon 2011 {published and unpublished data}
    1. Tandon R, Gupta N, Kalaivani M, Sharma N, Titiyal JS, Vajpayee RB. Amniotic membrane transplantation as an adjunct to medical therapy in acute ocular burns. British Journal of Ophthalmology 2011;95(2):199-204. - PubMed

References to studies excluded from this review

Arora 2005 {published data only}
    1. Arora R, Mehta D, Jain V. Amniotic membrane transplantation in acute chemical burns. Eye 2005;19(3):273-8. - PubMed
López‐García 2006 {published data only}
    1. López-García JS, Rivas L, García-Lozano I, Murube J. Analysis of corneal surface evolution after moderate alkaline burns by using impression cytology. Cornea 2006;25(8):908-13. - PubMed
López‐García 2007 {published data only}
    1. López-García JS, Rivas Jara L, García-Lozano I, Murube J. Histopathologic limbus evolution after alkaline burns. Cornea 2007;26(9):1043-8. - PubMed
Meller 2000 {published data only}
    1. Meller D, Pires RT, Mack RJ, Figueiredo F, Heiligenhaus A, Park WC, et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 2000;107(5):980-9. - PubMed
Muraine 2001 {published data only}
    1. Muraine M, Descargues G, Franck O, Villeroy F, Toubeau D, Menguy E, et al. Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases [La greffe de membrane amniotique dans les pathologies oculaires de surface. Etude prospective a partir de 31 cas]. Journal Francais d' Opthalmologie 2001;24(8):798-812. - PubMed
Sharma 2016 {published data only (unpublished sought but not used)}
    1. Sharma N, Singh D, Maharana PK, Kriplani A, Velpandian T, Pandey RM, et al. Comparison of amniotic membrane transplantation and umbilical cord serum in acute ocular chemical burns: a randomized controlled trial. American Journal of Ophthalmology 2016;168:157-63. - PubMed
Tamhane 2005 {published data only (unpublished sought but not used)}
    1. Tamhane A, Vajpayee RB, Biswas NR, Pandey RM, Sharma N, Titiyal JS, et al. Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. Ophthalmology 2005;112(11):1963-9. - PubMed

Additional references

Ang 2021
    1. Ang M, Foo V, Ke M, Tan B, Tong L, Schmetterer L, et al. Role of anterior segment optical coherence tomography angiography in assessing limbal vasculature in acute chemical injury of the eye. British Journal of Ophthalmology 2021. [DOI: 10.1136/bjophthalmol-2021-318847] - DOI - PubMed
Bagley 2006
    1. Bagley DM, Casterton PL, Dressler WE, Edelhauser HF, Kruszewski FH, McCulley JP, et al. Proposed new classification scheme for chemical injury to the human eye. Regulatory Toxicology and Pharmacology 2006;45(2):206-13. - PubMed
Ballen 1964
    1. Ballen PH. Treatment of chemical burns of the eye. Eye, Ear, Nose and Throat Monthly 1964;43:57-61. - PubMed
Baum 2002
    1. Baum J. Thygeson lecture. Amniotic membrane transplantation: why is it effective? Cornea 2002;21(4):339-41. - PubMed
Bizrah 2019
    1. Bizrah M, Yusuf A, Ahmad S. An update on chemical eye burns. Eye 2019;33(9):1362-77. - PMC - PubMed
Cotsarelis 1989
    1. Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell 1989;57(2):201-9. - PubMed
Davanger 1971
    1. Davanger M, Evensen A. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature 1971;229(5286):560-1. - PubMed
Dua 2001
    1. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. British Journal of Ophthalmology 2001;85(11):1379-83. - PMC - PubMed
Dua 2020
    1. Dua HS, Ting DS, Al Saadi A, Said DG. Chemical eye injury: pathophysiology, assessment and management. Eye 2020;34(11):2001-19. - PMC - PubMed
Fung 2019
    1. Fung SS, Stewart RM, Dhallu SK, Sim DA, Keane PA, Wilkins MR, et al. Anterior segment optical coherence tomographic angiography assessment of acute chemical injury. American Journal of Ophthalmology 2019;205:165-74. - PubMed
Glanville 2006
    1. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6. - PMC - PubMed
Gupta 2011
    1. Gupta N, Kalaivani M, Tandon R. Comparison of prognostic value of Roper Hall and Dua classification systems in acute ocular burns. British Journal of Ophthalmology 2011;95(2):194-8. - PubMed
Haring 2016
    1. Haring RS, Sheffield ID, Channa R, Canner JK, Schneider EB. Epidemiologic trends of chemical ocular burns in the United States. JAMA Ophthalmology 2016;134(10):1119-24. - PubMed
Harun 2004
    1. Harun S, Srinivasan S, Hollingworth K, Batterbury M, Kaye S. Modification of classification of ocular chemical injuries. British Journal of Ophthalmology 2004;88(10):1353-4. - PMC - PubMed
Higgins 2017
    1. Higgins JP, Altman DG, Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Available from www.training.cochrane.org/handbook.
Kam 2019
    1. Kam KW, Patel CN, Nikpoor N, Yu M, Basu S. Limbal ischemia: reliability of clinical assessment and implications in the management of ocular burns. Indian Journal of Ophthalmology 2019;67(1):32-6. - PMC - PubMed
Kim 2000
    1. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Experimental Eye Research 2000;70(3):329-37. - PubMed
Kinoshita 1982
    1. Kinoshita S, Kiorpes TC, Friend J, Thoft RA. Limbal epithelium in ocular surface wound healing. Investigative Ophthalmology and Visual Science 1982;23(1):73-80. - PubMed
Klifto 2019
    1. Klifto KM, Elhelali A, Gurno C F, Seal SM, Asif M, Hultman CS. Acute surgical vs non-surgical management for ocular and peri-ocular burns: a systematic review and meta-analysis. Burns Trauma 2019;7:25. - PMC - PubMed
Kuckelkorn 1995a
    1. Kuckelkorn R, Kottek A, Schrage N, Reim M. Poor prognosis of severe chemical and thermal eye burns: the need for adequate emergency care and primary prevention. International Archives of Occupational and Environmental Health 1995;67(4):281-4. - PubMed
Kuckelkorn 1995b
    1. Kuckelkorn R, Schrage N, Reim M. Treatment of severe eye burns by Tenon-plasty. Lancet 1995;345(8950):657-8. - PubMed
Le 2018
    1. Le Q, Xu J, Deng SX. The diagnosis of limbal stem cell deficiency. Ocular Surface 2018;16(1):58-69. - PMC - PubMed
Le 2019
    1. Le Q, Deng SX. The application of human amniotic membrane in the surgical management of limbal stem cell deficiency. Ocular Surface 2019;17(2):221-9. - PMC - PubMed
Liu 2012
    1. Liu T, Zhai H, Xu Y, Dong Y, Sun Y, Zang X, et al. Amniotic membrane traps and induces apoptosis of inflammatory cells in ocular surface chemical burn. Molecular Vision 2012;18:2137-46. - PMC - PubMed
Loon 2009
    1. Loon SC, Tay WT, Saw SM, Wang JJ, Wong TY. Prevalence and risk factors of ocular trauma in an urban south-east Asian population: the Singapore Malay Eye Study. Clinical and Experimental Ophthalmology 2009;37(4):362-7. - PubMed
Macdonald 2009
    1. Macdonald EC, Cauchi PA, Azuara-Blanco A, Foot B. Surveillance of severe chemical corneal injuries in the UK. British Journal of Ophthalmology 2009;93(9):1177-80. - PubMed
Mamede 2012
    1. Mamede AC, Carvalho MJ, Abrantes AM, Laranjo M, Maia CJ, Botelho MF. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Research 2012;349(2):447-58. - PubMed
McCulley 1987
    1. McCulley JP. The Cornea: Scientific Foundation and Clinical Practice. 2nd edition. Boston: Little, Brown and Co, 1987.
Murdoch 1998
    1. Murdoch IE, Morris SS, Cousens SN. People and eyes: statistical approaches in ophthalmology. British Journal of Ophthalmology 1998;82(8):971-3. - PMC - PubMed
Nowell 2017
    1. Nowell CS, Radtke F. Corneal epithelial stem cells and their niche at a glance. Journal of Cell Science 2017;130(6):1021-5. - PubMed
Paolin 2016
    1. Paolin A, Trojan D, Leonardi A, Mellone S, Volpe A, Orlandi A, et al. Cytokine expression and ultrastructural alterations in fresh-frozen, freeze-dried and gamma-irradiated human amniotic membranes. Cell Tissue Bank 2016;17(3):399-406. - PMC - PubMed
Rao 1999
    1. Rao SK, Rajagopal R, Sitalakshmi G, Padmanabhan P. Limbal autografting: comparison of results in the acute and chronic phases of ocular surface burns. Cornea 1999;18(2):164-71. - PubMed
Ratnapalan 2011
    1. Ratnapalan S, Das L. Causes of eye burns in children. Pediatric Emergency Care 2011;27(2):151-6. - PubMed
RevMan Web 2022 [Computer program]
    1. Review Manager Web (RevMan Web) . Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.
Roper‐Hall 1965
    1. Roper-Hall MJ. Thermal and chemical burns. Transactions of the Ophthalmological Society of the United Kingdom 1965;85:631-53. - PubMed
Sahay 2019
    1. Sahay P, Goel S, Maharana P K, Sharma N. Amniotic membrane transplantation in acute severe ocular chemical injury: a randomized clinical trial. American Journal of Ophthalmology 2019;205:202-3. - PubMed
Schünemann 2011
    1. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JP, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Shafto 1950
    1. Shafto CM. A simple method of inserting amniotic membrane grafts into the conjunctival sac. British Journal of Ophthalmology 1950;34(7):445-6. - PMC - PubMed
Sharma 2015
    1. Sharma N, Lathi SS, Sehra SV, Agarwal T, Sinha R, Titiyal JS, et al. Comparison of umbilical cord serum and amniotic membrane transplantation in acute ocular chemical burns. British Journal of Ophthalmology 2015;99(5):669-73. - PubMed
Sharma 2018
    1. Sharma N, Kaur M, Agarwal T, Sangwan VS, Vajpayee RB. Treatment of acute ocular chemical burns. Survey of Ophthalmology 2018;63(2):214-35. - PubMed
Shimazaki 1997
    1. Shimazaki K, Yang HY, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 1997;104(12):2068-76. - PubMed
Shortt 2007
    1. Shortt AJ, Secker GA, Munro PM, Khaw PT, Tuft SJ, Daniels JT. Characterization of the limbal epithelial stem cell niche: novel imaging techniques permit in vivo observation and targeted biopsy of limbal epithelial stem cells. Stem Cells 2007;25(6):1402-9. - PubMed
Smith 2004
    1. Smith VA, Cook SD. Doxycycline - a role in ocular surface repair. British Journal of Ophthalmology 2004;88(5):619–25. - PMC - PubMed
Tseng 2004
    1. Tseng SC, Espana EM, Kawakita T, Di Pascuale MA, Li W, He H, et al. How does amniotic membrane work? Ocular Surface 2004;2(3):177-87. - PubMed
Vajpayee 2014
    1. Vajpayee RB, Shekhar H, Sharma N, Jhanji V. Demographic and clinical profile of ocular chemical injuries in the pediatric age group. Ophthalmology 2014;121(1):377-80. - PubMed
Wagoner 1997
    1. Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Survey of Ophthalmology 1997;41(4):275-313. - PubMed
Westekemper 2017
    1. Westekemper H, Figueiredo FC, Siah WF, Wagner N, Steuhl KP, Meller D. Clinical outcomes of amniotic membrane transplantation in the management of acute ocular chemical injury. British Journal of Ophthalmology 2017;101(2):103-7. - PubMed
Wong 2000
    1. Wong TY, Klein BE, Klein R. The prevalence and 5-year incidence of ocular trauma. The Beaver Dam Eye Study. Ophthalmology 2000;107(12):2196-202. - PubMed
Wong 2018
    1. Wong MY, Man RE, Gupta P, Sabanayagam C, Wong TY, Cheng CY, et al. Prevalence, subtypes, severity and determinants of ocular trauma: The Singapore Chinese Eye Study. British Journal of Ophthalmology 2018;102(2):204-9. - PubMed
Xiang 2005
    1. Xiang H, Stallones L, Chen G, Smith GA. Work-related eye injuries treated in hospital emergency departments in the US. American Journal of Industrial Medicine 2005;48(1):57-62. - PubMed

References to other published versions of this review

Clare 2011
    1. Clare G, Suleman H, Bunce C, Dua H. Amniotic membrane transplantation for acute ocular burns. Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No: CD009379. [DOI: 10.1002/14651858.CD009379] - DOI - PMC - PubMed
Clare 2012
    1. Clare G, Suleman H, Bunce C, Dua H. Amniotic membrane transplantation for acute ocular burns. Cochrane Database of Systematic Reviews 12 September 2012, Issue 9. Art. No: CD009379. [DOI: 10.1002/14651858.CD009379.pub2] - DOI - PMC - PubMed